セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/31 | 2,825 | 3,030 | 2,802 | 2,956 | +81 | +2.8% | 408,600 |
| 2022/03/30 | 2,710 | 2,894 | 2,690 | 2,875 | +202 | +7.6% | 433,800 |
| 2022/03/29 | 2,569 | 2,679 | 2,552 | 2,673 | +154 | +6.1% | 222,600 |
| 2022/03/28 | 2,632 | 2,644 | 2,490 | 2,519 | -125 | -4.7% | 222,400 |
| 2022/03/25 | 2,707 | 2,737 | 2,631 | 2,644 | -62 | -2.3% | 281,000 |
| 2022/03/24 | 2,497 | 2,719 | 2,490 | 2,706 | +171 | +6.7% | 470,100 |
| 2022/03/23 | 2,432 | 2,589 | 2,388 | 2,535 | +153 | +6.4% | 754,500 |
| 2022/03/22 | 2,643 | 2,662 | 2,364 | 2,382 | -261 | -9.9% | 1,077,800 |
| 2022/03/18 | 2,430 | 2,794 | 2,402 | 2,643 | -187 | -6.6% | 1,950,500 |
| 2022/03/17 | 2,830 | 2,830 | 2,830 | 2,830 | -700 | -19.8% | 78,800 |
| 2022/03/16 | 3,420 | 3,560 | 3,280 | 3,530 | +215 | +6.5% | 484,900 |
| 2022/03/15 | 3,195 | 3,340 | 3,095 | 3,315 | +95 | +3% | 215,700 |
| 2022/03/14 | 3,320 | 3,385 | 3,160 | 3,220 | -105 | -3.2% | 187,100 |
| 2022/03/11 | 3,320 | 3,430 | 3,260 | 3,325 | -80 | -2.3% | 145,800 |
| 2022/03/10 | 3,525 | 3,545 | 3,370 | 3,405 | +40 | +1.2% | 205,900 |
| 2022/03/09 | 3,555 | 3,555 | 3,280 | 3,365 | -35 | -1% | 177,700 |
| 2022/03/08 | 3,205 | 3,515 | 3,200 | 3,400 | +135 | +4.1% | 250,400 |
| 2022/03/07 | 3,220 | 3,340 | 3,150 | 3,265 | -155 | -4.5% | 216,700 |
| 2022/03/04 | 3,550 | 3,550 | 3,330 | 3,420 | -285 | -7.7% | 426,700 |
| 2022/03/03 | 4,185 | 4,205 | 3,655 | 3,705 | -130 | -3.4% | 664,700 |
| 2022/03/02 | 3,735 | 3,865 | 3,550 | 3,835 | -10 | -0.3% | 487,100 |
| 2022/03/01 | 3,640 | 3,865 | 3,505 | 3,845 | +415 | +12.1% | 663,900 |
| 2022/02/28 | 3,295 | 3,525 | 3,215 | 3,430 | +260 | +8.2% | 692,500 |
| 2022/02/25 | 3,145 | 3,195 | 3,060 | 3,170 | +200 | +6.7% | 191,800 |
| 2022/02/24 | 3,015 | 3,090 | 2,932 | 2,970 | -115 | -3.7% | 208,500 |
| 2022/02/22 | 3,105 | 3,215 | 3,055 | 3,085 | -110 | -3.4% | 199,900 |
| 2022/02/21 | 3,225 | 3,250 | 3,105 | 3,195 | -130 | -3.9% | 125,500 |
| 2022/02/18 | 3,265 | 3,360 | 3,200 | 3,325 | -25 | -0.7% | 132,700 |
| 2022/02/17 | 3,450 | 3,460 | 3,330 | 3,350 | -170 | -4.8% | 107,700 |
| 2022/02/16 | 3,535 | 3,580 | 3,465 | 3,520 | +120 | +3.5% | 97,600 |
| 2022/02/15 | 3,475 | 3,555 | 3,390 | 3,400 | -100 | -2.9% | 116,000 |
| 2022/02/14 | 3,610 | 3,625 | 3,460 | 3,500 | -270 | -7.2% | 135,300 |
| 2022/02/10 | 3,800 | 3,840 | 3,730 | 3,770 | +70 | +1.9% | 100,600 |
| 2022/02/09 | 3,615 | 3,725 | 3,535 | 3,700 | +50 | +1.4% | 137,500 |
| 2022/02/08 | 3,735 | 3,770 | 3,585 | 3,650 | -15 | -0.4% | 97,200 |
| 2022/02/07 | 3,805 | 3,845 | 3,625 | 3,665 | -140 | -3.7% | 94,500 |
| 2022/02/04 | 3,765 | 3,845 | 3,630 | 3,805 | -10 | -0.3% | 182,300 |
| 2022/02/03 | 3,980 | 4,005 | 3,725 | 3,815 | -175 | -4.4% | 155,500 |
| 2022/02/02 | 4,050 | 4,060 | 3,860 | 3,990 | +135 | +3.5% | 131,300 |
| 2022/02/01 | 4,070 | 4,075 | 3,825 | 3,855 | +65 | +1.7% | 204,900 |
| 2022/01/31 | 3,635 | 3,880 | 3,595 | 3,790 | +225 | +6.3% | 251,200 |
| 2022/01/28 | 3,600 | 3,690 | 3,455 | 3,565 | +25 | +0.7% | 174,200 |
| 2022/01/27 | 3,920 | 3,935 | 3,500 | 3,540 | -420 | -10.6% | 355,700 |
| 2022/01/26 | 3,865 | 4,000 | 3,830 | 3,960 | +100 | +2.6% | 129,000 |
| 2022/01/25 | 4,295 | 4,405 | 3,770 | 3,860 | -365 | -8.6% | 332,900 |
| 2022/01/24 | 4,150 | 4,280 | 4,015 | 4,225 | +5 | +0.1% | 155,300 |
| 2022/01/21 | 4,235 | 4,325 | 4,090 | 4,220 | -125 | -2.9% | 157,800 |
| 2022/01/20 | 4,160 | 4,405 | 4,130 | 4,345 | +140 | +3.3% | 261,500 |
| 2022/01/19 | 4,365 | 4,505 | 4,190 | 4,205 | -300 | -6.7% | 229,500 |
| 2022/01/18 | 4,440 | 4,625 | 4,300 | 4,505 | +80 | +1.8% | 284,800 |
651～
700
件表示中 / 1240件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
